1-[(2-chloro-4-pyridinyl)methyl]-6-methyl-2-oxo-N-[4-(trifluoromethoxy)phenyl]pyridine-3-carboxamide;6-methyl-1-[[2-(4-methylpiperazin-1-yl)-4-pyridinyl]methyl]-2-oxo-N-[4-(trifluoromethoxy)phenyl]pyridine-3-carboxamide;1-methylpiperazine
C50H53ClF6N10O6 — CID 159826646
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[(2-chloro-4-pyridinyl)methyl]-6-methyl-2-oxo-N-[4-(trifluoromethoxy)phenyl]pyridine-3-carboxamide;6-methyl-1-[[2-(4-methylpiperazin-1-yl)-4-pyridinyl]methyl]-2-oxo-N-[4-(trifluoromethoxy)phenyl]pyridine-3-carboxamide;1-methylpiperazine
1-[(2-chloro-4-pyridinyl)methyl]-6-methyl-2-oxo-N-[4-(trifluoromethoxy)phenyl]pyridine-3-carboxamide;6-methyl-1-[[2-(4-methylpiperazin-1-yl)-4-pyridinyl]methyl]-2-oxo-N-[4-(trifluoromethoxy)phenyl]pyridine-3-carboxamide;1-methylpiperazine (PubChem CID 159826646) has the molecular formula C50H53ClF6N10O6 and a molecular weight of 1039.48 g/mol. Its IUPAC name is 1-[(2-chloro-4-pyridinyl)methyl]-6-methyl-2-oxo-N-[4-(trifluoromethoxy)phenyl]pyridine-3-carboxamide;6-methyl-1-[[2-(4-methylpiperazin-1-yl)-4-pyridinyl]methyl]-2-oxo-N-[4-(trifluoromethoxy)phenyl]pyridine-3-carboxamide;1-methylpiperazine.
Molecular Properties
| Compound Name | 1-[(2-chloro-4-pyridinyl)methyl]-6-methyl-2-oxo-N-[4-(trifluoromethoxy)phenyl]pyridine-3-carboxamide;6-methyl-1-[[2-(4-methylpiperazin-1-yl)-4-pyridinyl]methyl]-2-oxo-N-[4-(trifluoromethoxy)phenyl]pyridine-3-carboxamide;1-methylpiperazine |
|---|---|
| PubChem CID | 159826646 |
| Molecular Formula | C50H53ClF6N10O6 |
| Molecular Weight | 1039.48 g/mol |
| Exact Mass | 1038.37 |
| IUPAC Name | 1-[(2-chloro-4-pyridinyl)methyl]-6-methyl-2-oxo-N-[4-(trifluoromethoxy)phenyl]pyridine-3-carboxamide;6-methyl-1-[[2-(4-methylpiperazin-1-yl)-4-pyridinyl]methyl]-2-oxo-N-[4-(trifluoromethoxy)phenyl]pyridine-3-carboxamide;1-methylpiperazine |
| SMILES | CN1CCNCC1.Cc1ccc(C(=O)Nc2ccc(OC(F)(F)F)cc2)c(=O)n1Cc1ccnc(Cl)c1.Cc1ccc(C(=O)Nc2ccc(OC(F)(F)F)cc2)c(=O)n1Cc1ccnc(N2CCN(C)CC2)c1 |
| InChI | InChI=1S/C25H26F3N5O3.C20H15ClF3N3O3.C5H12N2/c1-17-3-8-21(23(34)30-19-4-6-20(7-5-19)36-25(26,27)28)24(35)33(17)16-18-9-10-29-22(15-18)32-13-11-31(2)12-14-32;1-12-2-7-16(19(29)27(12)11-13-8-9-25-17(21)10-13)18(28)26-14-3-5-15(6-4-14)30-20(22,23)24;1-7-4-2-6-3-5-7/h3-10,15H,11-14,16H2,1-2H3,(H,30,34);2-10H,11H2,1H3,(H,26,28);6H,2-5H2,1H3 |
| InChIKey | NMXPJUQZQXGTDW-UHFFFAOYSA-N |
| XLogP | 7.43 |
| TPSA | 168.19 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 14 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 73 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1039.48 |
| LogP ≤ 5 | 7.43 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 14 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159826646 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.